Complement 3-deficient mice are not protected against MPTP-induced dopaminergic neurotoxicity
Authors:
- Yajie LiangYLYajie Liang
- Shurong LiSLShurong Li
- Qiang GuoQGQiang Guo
- Yanliang ZhangYZYanliang Zhang
- Can WenCWCan Wen
- Qiang ZouQZQiang Zou
- Bingyin SuBSBingyin Su
- 31 October 2007
- journal article
- Published by Elsevier in Brain Research
- Vol. 1178 (1) , 132-140
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- C3a expressed in the central nervous system protects against LPS-induced shockNeuroscience Letters, 2005
- Regulation of mast cell activation by complement-derived peptidesImmunology Letters, 2004
- Caspase-11 Mediates Inflammatory Dopaminergic Cell Death in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson's DiseaseThe Journal of Neuroscience, 2004
- Parkinson's DiseaseNeuron, 2003
- Critical role of microglial NADPH oxidase‐derived free radicals in the in vitro MPTP model of Parkinson's diseaseThe FASEB Journal, 2003
- Critical Role for Microglial NADPH Oxidase in Rotenone-Induced Degeneration of Dopaminergic NeuronsThe Journal of Neuroscience, 2003
- Expression of the complement C3a and C5a receptors after permanent focal ischemia: An alternative interpretationGlia, 2002
- Spontaneous long-term compensatory dopaminergic sprouting in MPTP-treated miceSynapse, 2000
- Parkinsonian serum carries complement-dependent toxicity for rat mesencephalic dopaminergic neurons in cultureBrain Research, 1994
- Estimation of nuclear population from microtome sectionsThe Anatomical Record, 1946